Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland

被引:12
|
作者
Freire Soares Marques, Yonara Maria [1 ]
Moura de Lima, Marina de Deus [1 ]
Alves, Sergio de Melo [1 ]
Soares, Fernando Augusto [2 ]
de Araujo, Vera Cavalcanti [3 ]
Pinto, Decio dos Santos [1 ]
Mantesso, Andrea [1 ]
机构
[1] Univ Sao Paulo, Sch Dent, Dept Oral Pathol, Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Dent, Dept Pathol, Sao Paulo, Brazil
[3] Sao Leopoldo Mandic Dent Res Inst, Dept Oral Pathol, Sao Paulo, Brazil
关键词
Mdm2; p53; p2l; pAkt; pleomorphic adenoma; myoepithehoma;
D O I
10.1016/j.oraloncology.2007.11.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p53 protein can be altered virtually in all. human cancers. In the absence of p53 mutations, p53 inactivation is possible via complex formation with other proteins, such as Mdm2. Previous studies have shown an overexpression of Mdm2 and lack of p53 expression in pleomorphic adenomas. The pAkt protein is closely related to Mdm2, and has not been previously reported in salivary gland tumors. The aim of this study was to analyze the expression of Mdm2, p53, p21 and pAkt proteins in pleomorphic adenomas and myoepitheliomas by immunohistochemistry, Western blotting and immunofluorescence techniques. Overexpression of Mdm2 and pAkt was present in all the cell tines and tumors studied, whereas the expression of p53 and p21 proteins was considered absent. In conclusion, the signaling pathway in benign salivary gland neoplasm showed an important participation of Mdm2 overexpression protein in tumor formation, progression through inactivation of p53 action, or both, and of pAkt overexpression through increased translocation of Mdm2 protein to cellular nuclei. (C) 2007 Etsevier Ltd. All rights reserved.
引用
收藏
页码:903 / 908
页数:6
相关论文
共 50 条
  • [41] Profiling inhibitors of MDM2: p53 and MDMX: p53 in relation to MDMX protein levels
    Tudhope, Sue
    Zhao, Yan
    Wittner, Anita
    Wilmore, Elaine
    Bertoli, Annalisa
    Adhikari, Santosh
    Harnor, Suzannah J.
    Del Bello, Fabio
    Piergentili, Alessandro
    Lunec, John
    Hardcastle, Ian R.
    Griffin, Roger J.
    Golding, Bernard R.
    Cano, Celine
    Newell, David R.
    Wedge, Stephen R.
    CANCER RESEARCH, 2014, 74 (19)
  • [42] Hdmx stabilizes Mdm2 and p53
    Stad, R
    Ramos, YFM
    Little, N
    Grivell, S
    Attema, J
    van der Eb, AJ
    Jochemsen, AG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (36) : 28039 - 28044
  • [43] p53, mdm-2, and p21 waf-1 in the porokeratoses
    Nelson, C
    Cowper, S
    Morgan, M
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1999, 21 (05) : 420 - 425
  • [44] Slug promotes p53 and p21 protein degradation by inducing Mdm2 expression in HCT116 colon cancer cells
    Kim, Jongdoo
    Lee, Jihyun
    Kim, Ukjin
    Park, Jong-Kuk
    Um, Hong-Duck
    ONCOLOGY LETTERS, 2021, 22 (03)
  • [45] MDM2 liberates from p53
    Capoulade, C
    Wiels, J
    M S-MEDECINE SCIENCES, 1999, 15 (04): : 524 - 527
  • [46] Regulation of p53 stability by Mdm2
    Kubbutat, MHG
    Jones, SN
    Vousden, KH
    NATURE, 1997, 387 (6630) : 299 - 303
  • [47] MDM2: life without p53
    Daujat, S
    Neel, H
    Piette, J
    TRENDS IN GENETICS, 2001, 17 (08) : 459 - 464
  • [48] p53 mRNA and p53 Protein Structures Have Evolved Independently to Interact with MDM2
    Karakostis, Konstantinos
    Ponnuswamy, Anand
    Fusee, Leila T. S.
    Bailly, Xavier
    Laguerre, Laurent
    Worall, Erin
    Vojtesek, Borek
    Nylander, Karin
    Fahraeus, Robin
    MOLECULAR BIOLOGY AND EVOLUTION, 2016, 33 (05) : 1280 - 1292
  • [49] mdm2/p53与肿瘤
    金永丽
    王靖华
    陈龙邦
    临床肿瘤学杂志, 2007, (06) : 469 - 471
  • [50] p53和mdm2基因
    沈行良
    翁启芳
    中国热带医学, 2007, (01) : 103 - 105